Total androgen ablation in the treatment of metastatic prostatic cancer. The Canadian Anandron Study Group

Semin Urol. 1990 Aug;8(3):159-65.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actuarial Analysis
  • Aged
  • Androgen Antagonists / therapeutic use*
  • Combined Modality Therapy
  • Double-Blind Method
  • Humans
  • Imidazoles / therapeutic use*
  • Imidazolidines*
  • Male
  • Orchiectomy*
  • Prostatic Neoplasms / mortality
  • Prostatic Neoplasms / therapy*
  • Randomized Controlled Trials as Topic
  • Survival Rate

Substances

  • Androgen Antagonists
  • Imidazoles
  • Imidazolidines
  • nilutamide